LAURUSLABS logo

Laurus LABS Limited

F&O
LAURUSLABS·NSE·
1,856.50 -5.10 (-0.27%)
Market Cap100536.44 Cr
PE Ratio112.79
Volume21,44,050
Day High - Low1864.40 - 1811.70
52W High-Low1949.00 - 823.10
DocStoX Score
5.2/10
Weak
Fair Value
Sign in to see
ROE
18.30%
Strong
P/E
112.79x
Expensive
Debt / Equity
0.40
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 200NIFTY 500NIFTY MIDCAP 150
Day1812
1864
52W823.10
1949
DocStoX take

Supported by risk (8.9) and quality (7.6), but held back by valuation (0.0). Risk looks strong at 8.9, but that is offset by valuation at 0.0 and growth at 1.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.2
/10
Weak
Quality
Excellent
ROE 18.3%
Valuation
Expensive
P/E 112.8×
Growth
Flat
Revenue +7.2% 5Y CAGR
Risk
Low risk
D/E 0.40
Momentum
Strong
92% of 52-week range

At a glance

Market Cap
₹1.01L Cr
52W High / Low
₹1949 / ₹823
Dividend Yield
0.10%
Promoter Holding
27.47%
EPS (TTM)
₹16.46
Book Value
₹98.20

Key highlights

  • Profitable in all of the last 5 years
  • Strong returns on equity (18%)
  • Profit shrinking 2% a year
  • Valuation is weak (0.0/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

LAURUS LABS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.